Brittany L Smith1, Eric S Hall2,3,4, Jennifer M McAllister3,4,5, Michael P Marcotte3,6, Kenneth D R Setchell4,7, Vandana Megaraj7, Kristine L Jimenez7, T John Winhusen5,8, Scott L Wexelblatt9,10,11. 1. Department of Pharmacology & Systems Physiology, University of Cincinnati Reading Campus, Cincinnati, OH, USA. 2. Translational Data Science and Informatics, Geisinger, Danville, PA, USA. 3. Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 4. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 5. Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 6. Department of OB GYN, division of Maternal Fetal Medicine, TriHealth, Cincinnati, OH, USA. 7. Division of Pathology and Laboratory Medicine, Clinical Mass Spectrometry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. 8. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA. 9. Perinatal Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. scott.wexelblatt@cchmc.org. 10. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. scott.wexelblatt@cchmc.org. 11. Center for Addiction Research, University of Cincinnati College of Medicine, Cincinnati, OH, USA. scott.wexelblatt@cchmc.org.
Abstract
OBJECTIVE: To report substance and polysubstance use at the time of delivery. STUDY DESIGN: A cross-sectional study was performed on mothers consented for universal drug testing (99%) during hospital admission at six delivery hospitals in Cincinnati, Ohio. Mass spectrometry urinalysis detected positivity rates of 46 substances. Rates of positive drug tests for individual and common co-occurring substances measured were reported. RESULTS: 2531 maternal samples were tested (88%) and 33% contained cotinine, 11.3% THC, 7.2% opioids, 3.8% cocaine, and 1.9% methamphetamines. Polysubstance use prevalence was as high as 15%. Among mothers testing positive for methadone or buprenorphine, 93% also tested positive for cotinine and 39% tested positive for a third substance in addition to cotinine. CONCLUSIONS: Substance use at delivery is more prevalent than previously reported. Many mothers testing positive for opioids also test positive for other substances, which may increase overdose risk and exacerbate neonatal opioid withdrawal syndrome (NOWS).
OBJECTIVE: To report substance and polysubstance use at the time of delivery. STUDY DESIGN: A cross-sectional study was performed on mothers consented for universal drug testing (99%) during hospital admission at six delivery hospitals in Cincinnati, Ohio. Mass spectrometry urinalysis detected positivity rates of 46 substances. Rates of positive drug tests for individual and common co-occurring substances measured were reported. RESULTS: 2531 maternal samples were tested (88%) and 33% contained cotinine, 11.3% THC, 7.2% opioids, 3.8% cocaine, and 1.9% methamphetamines. Polysubstance use prevalence was as high as 15%. Among mothers testing positive for methadone or buprenorphine, 93% also tested positive for cotinine and 39% tested positive for a third substance in addition to cotinine. CONCLUSIONS: Substance use at delivery is more prevalent than previously reported. Many mothers testing positive for opioids also test positive for other substances, which may increase overdose risk and exacerbate neonatal opioid withdrawal syndrome (NOWS).
Authors: Elisha M Wachman; P K Newby; Joy Vreeland; John Byun; Anthony Bonzagni; Howard Bauchner; Barbara L Philipp Journal: J Addict Med Date: 2011-12 Impact factor: 3.702
Authors: Mohammad R Hayatbakhsh; Vicki J Flenady; Kristen S Gibbons; Ann M Kingsbury; Elizabeth Hurrion; Abdullah A Mamun; Jake M Najman Journal: Pediatr Res Date: 2011-12-21 Impact factor: 3.756
Authors: Margaret S Chisolm; Heather Fitzsimons; Jeannie-Marie S Leoutsakos; Shauna P Acquavita; Sarah H Heil; Molly Wilson-Murphy; Michelle Tuten; Karol Kaltenbach; Peter R Martin; Bernadette Winklbaur; Lauren M Jansson; Hendrée E Jones Journal: Nicotine Tob Res Date: 2013-01-03 Impact factor: 4.244
Authors: Robin E Choo; Marilyn A Huestis; Jennifer R Schroeder; Angela S Shin; Hendrée E Jones Journal: Drug Alcohol Depend Date: 2004-09-06 Impact factor: 4.492
Authors: Brittany L Smith; Tess A Guzman; Alexander H Brendle; Collin J Laaker; Alexis Ford; Adam R Hiltz; Junfang Zhao; Kenneth D R Setchell; Teresa M Reyes Journal: eNeuro Date: 2022-10-17